In a recent survey of nearly 100 pharmaceutical and life science market research executives conducted by my company InCrowd, 80% identified their respective brand as being in a volatile market, characterized by disruption and uncertainty.

Asia is one of the leading destinations for health tourism. Countries such as India, China, Malaysia, and Thailand are witnessing large numbers of medical tourists due to cheaper treatment costs and high-quality healthcare services. In 2016, Indians and Chinese spent around $68 and $431 per head respectively on medical treatment while Americans spent at least 19 times more. This is one of the key themes explored in The Business Research Company’s recent Healthcare Market Global Report 2017.

Do you have trouble falling asleep or staying asleep? You’re in good company, unfortunately.

According to consumer research firm Packaged Facts, 82% of American adults have difficulty sleeping at least once a week. This translates into 206 million American adults who are struggling to get a good night’s rest.

However, for many people, sleep issues aren't just an occasional problem. In fact, 39% of Americans have trouble sleeping five or more times a week, and a third of U.S. adults have a major sleep disorder.

President Donald Trump’s stated goal of lowering drug prices won’t be easy. The President told drugmakers at a White House meeting that prices were “astronomical” and hinted at negotiating with Medicare and reducing regulation on new drugs. Congress has also proposed more generic drugs as a way of saving on costs.

While lower drug prices is an admirable goal, an across-the-board reduction of pharmaceutical prices will face many obstacles and most likely would not happen, according to our research at Kalorama Information. If somehow, Congress and the administration were able to achieve a reduction, it might impair the creation of new drugs.

How will President Donald Trump affect the economy in the coming weeks and years? Which industries face the biggest shifts? How can you be prepared for what's next?

Several market research firms are weighing in as various issues jump to the forefront of the news cycle.

Here's a look at the latest #mrx tweets serving up data and analysis on the potential economic impact of Trump's presidency across different industries.

In a recent GMR Data report, figures indicate that revenues for the dermatology drug market will reach $83.2 billion in 2026 from a base of $31.6 billion in 2016.

The largest dermatology drug markets in 2016 include areas such as acne, worth $3.89 billion globally, skin infections ($6.59 billion), and skin cancer ($5.06 billion).

Robust sales in western markets, entrance of new drugs into emerging markets, and increasing prevalence of skin conditions are all driving the global forecast for the next decade.

Have you heard of aseptic packaging? It’s a type of packaging where the contents and the container are commercially sterilized separately and are then combined in a sterile environment.

The $4.6 billion aseptic packaging market accounted for three percent of US packaging in 2015. In unit terms, demand is expected to expand 3.7 percent annually to 68.5 billion in 2020. Read on to learn more about this growing market.

The U.S. demand for drug delivery products is projected to reach $251 billion in 2019, according to the Freedonia Group, a leading international business research company. Oral dosage formulations will remain the largest-selling group of drug delivery products over the long term, but patent expirations and competition from generic brands will soften the growth potential of this product segment overall. Drawing on key findings from Freedonia's recent study Drug Delivery Products, here’s a look at the market outlook for oral medications, including controlled-release formulations and niche applications.

China possesses a large healthcare market that is indispensable for overseas and multinational pharmaceutical companies. In 2014, the total value of drugs in the Chinese healthcare market reached RMB 1332.6 billion (approx. US$214.9 billion). Imported drugs made by overseas and multinational companies accounted for around one-fourth of the Chinese healthcare market.

The global smoking cessation market is going from strength to strength, globally, with ever increasing products coming to the market both prescription and over-the-counter (OTC). Most notable are the range of Vaping (e-cigarettes/smokeless cigarettes) products, a market which was estimated to be worth over $3 billion across both 2013 and 2014. So, where has this market come from?